Literature DB >> 32902868

Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis.

Chia Siang Kow1, Syed Shahzad Hasan2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32902868     DOI： 10.1002/jmv.26498

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


× No keyword cloud information.
  28 in total

1.  Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19.

Authors:  Pandora L Wander; Elliott Lowy; Lauren A Beste; Luis Tulloch-Palomino; Anna Korpak; Alexander C Peterson; Bessie A Young; Edward J Boyko
Journal:  BMJ Open Diabetes Res Care       Date:  2021-06

Review 2.  Associations and Disease-Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.

Authors:  Altijana Hromić-Jahjefendić; Debmalya Barh; Cecília Horta Ramalho Pinto; Lucas Gabriel Rodrigues Gomes; Jéssica Lígia Picanço Machado; Oladapo Olawale Afolabi; Sandeep Tiwari; Alaa A A Aljabali; Murtaza M Tambuwala; Ángel Serrano-Aroca; Elrashdy M Redwan; Vladimir N Uversky; Kenneth Lundstrom
Journal:  Viruses       Date:  2022-04-27       Impact factor: 5.818

Review 3.  Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews.

Authors:  Jamie Hartmann-Boyce; Karen Rees; James C Perring; Sven A Kerneis; Elizabeth M Morris; Clare Goyder; Afolarin A Otunla; Olivia A James; Nandana R Syam; Samuel Seidu; Kamlesh Khunti
Journal:  Diabetes Care       Date:  2021-10-28       Impact factor: 17.152

4.  Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Tiantian Han; Shaodi Ma; Chenyu Sun; Huimei Zhang; Guangbo Qu; Yue Chen; Ce Cheng; Eric L Chen; Mubashir Ayaz Ahmed; Keun Young Kim; Raveena Manem; Mengshi Chen; Zhichun Guo; Hongru Yang; Yue Yan; Qin Zhou
Journal:  Arch Med Res       Date:  2021-08-09       Impact factor: 2.235

5.  Glucose-lowering treatments and COVID-19 mortality in T2DM.

Authors:  Samy Hadjadj; Matthieu Wargny
Journal:  Nat Rev Endocrinol       Date:  2021-05-12       Impact factor: 43.330

Review 6.  Metformin: A Novel Weapon Against Inflammation.

Authors:  Bo Bai; Haibo Chen
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

7.  Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus?

Authors:  Gilbert Lazarus; Indira P Suhardi; Elvan Wiyarta; Rufiah A Rasyidah; Julie D Barliana
Journal:  Int J Diabetes Dev Ctries       Date:  2021-03-02

8.  COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; M Alblihed; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Front Med (Lausanne)       Date:  2021-02-19

9.  Paradoxical low severity of COVID-19 in Prader-Willi syndrome: data from a French survey on 647 patients.

Authors:  Muriel Coupaye; Virginie Laurier; Grégoire Benvegnu; Christine Poitou; Pauline Faucher; Héléna Mosbah; Gwenaelle Diene; Graziella Pinto; Laura González Briceño; Christine Merrien; Ana Camarena Toyos; Emilie Montastier; Maithé Tauber; Fabien Mourre
Journal:  Orphanet J Rare Dis       Date:  2021-07-21       Impact factor: 4.123

10.  Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes.

Authors:  Jingya Wang; Jennifer M Cooper; Krishna Gokhale; Dionisio Acosta-Mena; Samir Dhalla; Nathan Byne; Joht Singh Chandan; Astha Anand; Kelvin Okoth; Anuradhaa Subramanian; Mansoor N Bangash; Thomas Jackson; Dawit Zemedikun; Tom Taverner; Wasim Hanif; Sandip Ghosh; Parth Narendran; Konstantinos A Toulis; Abd A Tahrani; Rajendra Surenthirakumaran; Nicola J Adderley; Shamil Haroon; Kamlesh Khunti; Christopher Sainsbury; G Neil Thomas; Krishnarajah Nirantharakumar
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.